Development
Bruker Corporation
BRKR
$34.54
$2.186.74%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 2.95B | 2.81B | 2.71B | 2.61B | 2.52B |
| Total Other Revenue | 15.80M | 8.90M | 10.30M | 12.00M | 10.70M |
| Total Revenue | 2.96B | 2.82B | 2.71B | 2.62B | 2.53B |
| Cost of Revenue | 1.45B | 1.37B | 1.31B | 1.26B | 1.22B |
| Gross Profit | 1.52B | 1.45B | 1.40B | 1.36B | 1.31B |
| SG&A Expenses | 727.30M | 685.00M | 657.50M | 636.90M | 620.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 13.10M | 8.00M | -300.00K | -5.50M | -5.50M |
| Total Operating Expenses | 2.48B | 2.34B | 2.23B | 2.14B | 2.07B |
| Operating Income | 484.10M | 482.80M | 485.00M | 480.70M | 456.50M |
| Income Before Tax | 546.20M | 426.20M | 436.30M | 428.20M | 414.90M |
| Income Tax Expenses | 117.70M | 104.00M | 114.40M | 114.40M | 116.40M |
| Earnings from Continuing Operations | 428.50 | 322.20 | 321.90 | 313.80 | 298.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.30M | -3.10M | -2.80M | -2.30M | -1.90M |
| Net Income | 427.20M | 319.10M | 319.10M | 311.50M | 296.60M |
| EBIT | 484.10M | 482.80M | 485.00M | 480.70M | 456.50M |
| EBITDA | 599.00M | 584.90M | 581.50M | 572.90M | 545.30M |
| EPS Basic | 2.92 | 2.17 | 2.17 | 2.11 | 2.00 |
| Normalized Basic EPS | 2.07 | 1.96 | 1.98 | 1.93 | 1.85 |
| EPS Diluted | 2.92 | 2.17 | 2.16 | 2.10 | 1.99 |
| Normalized Diluted EPS | 2.06 | 1.95 | 1.97 | 1.92 | 1.84 |
| Average Basic Shares Outstanding | 585.70M | 587.30M | 588.50M | 590.70M | 594.30M |
| Average Diluted Shares Outstanding | 588.60M | 590.50M | 591.80M | 593.90M | 597.70M |
| Dividend Per Share | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Payout Ratio | 6.88% | 9.24% | 9.24% | 9.53% | 10.05% |